Patient selection, prognostic markers and outcomes in inflammatory airway disease

Created and Presented by: Rhinology And Skull Base Research Group, Continuing Medical Education Dinner Meeting

A live webinar and dinner educational event.

• Prof Constance Katelaris: Heterogeneity and similarities of action between biologics
• A/Prof Janet Rimmer: Biologics – Responders and non-responders of the lower airway
• Prof Richard Harvey: Biologics – Responders and non-responders of the upper airway

ZEST Waterfront – 21 Wunulla Road Point Piper 2027
(located at the Royal Motor Yacht club)

Dinner meeting: 7:00pm – 9:30pm
Webinar session: 7:30pm – 9:30pm

Your personal information (“Information”) will be collected and used by AstraZeneca Pty Ltd (“AstraZeneca”) to register you for this event, for follow up purposes and for any other purpose described in AstraZeneca’s Privacy Policy. AstraZeneca may disclose your Information to our related entities or service providers (including IT support/service providers), some of which may be located overseas including in the US, European Union and Asia Pacific. If you do not provide your Information, AstraZeneca will not be able to register you for this event. Please refer to our Privacy Policy at for more information about how your Information is handled and how you may seek to access or correct your Information, or submit a privacy complaint. AU-9861, February 2021.

For enquiries please contact:
Marie Urriste

For in-person meeting, register here:
For virtual meeting, register here:

mepoluzimab benralizumab duplimab sinusitis nasal polyps